In last trading session, Cullinan Therapeutics Inc (NASDAQ:CGEM) saw 0.32 million shares changing hands with its beta currently measuring -0.16. Company’s recent per share price
Cullinan Therapeutics Inc (NASDAQ:CGEM)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting -0.16. At the close of
In last trading session, Cullinan Therapeutics Inc (NASDAQ:CGEM) saw 0.41 million shares changing hands with its beta currently measuring -0.16. Company’s recent per share price
During the last session, Cullinan Therapeutics Inc (NASDAQ:CGEM)’s traded shares were 0.62 million, with the beta value of the company hitting -0.18. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
